PDF herunterladen
Semin Thromb Hemost 2017; 43(05): 486-492
DOI: 10.1055/s-0036-1597287
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Prognostic Scores for Acute Pulmonary Embolism

Raquel Morillo
1   Respiratory Department, Ramón y Cajal Hospital, IRYCIS and Alcala de Henares University, Madrid, Spain
,
Lisa Moores
2   F. Edward Hebert School of Medicine, Uniformed Services University, Bethesda, Maryland
,
David Jiménez
1   Respiratory Department, Ramón y Cajal Hospital, IRYCIS and Alcala de Henares University, Madrid, Spain
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
06. Februar 2017 (online)

    Lizenzen und Reprints

Abstract

Rapid and accurate risk stratification is critical in determining the optimal treatment strategy for patients with acute pulmonary embolism (PE). Early identification of patients with normal blood pressure and a favorable prognosis (low-risk PE) might select a subset of patients for outpatient treatment, which is associated with reduced cost and improved patient satisfaction, and has been shown to be effective and safe. Alternatively, identification of normotensive patients deemed as having a high risk for PE-related adverse clinical events (intermediate-high-risk PE) might select a subset of patients for close observation and consideration of escalation of therapy. Clinical prognostic scores have been gaining importance in the classification of patients into these categories. They should be derived and validated following strict methodological standards, and their use in clinical practice should be encouraged.

Keywords

pulmonary embolism - scores - prognosis - mortality - survival
 

  • References

  • 1 Jiménez D, de Miguel-Díez J, Guijarro R. , et al; RIETE Investigators. Trends in the management and outcomes of acute pulmonary embolism: analysis from the RIETE registry. J Am Coll Cardiol 2016; 67 (02) 162-170
    CrossrefPubMedGoogle Scholar
  • 2 Laporte S, Mismetti P, Décousus H. , et al; RIETE Investigators. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation 2008; 117 (13) 1711-1716
    CrossrefPubMedGoogle Scholar
  • 3 Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998; 279 (06) 458-462
    CrossrefPubMedGoogle Scholar
  • 4 Conget F, Otero R, Jiménez D. , et al. Short-term clinical outcome after acute symptomatic pulmonary embolism. Thromb Haemost 2008; 100 (05) 937-942
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 5 Klok FA, Zondag W, van Kralingen KW. , et al. Patient outcomes after acute pulmonary embolism. A pooled survival analysis of different adverse events. Am J Respir Crit Care Med 2010; 181 (05) 501-506
    CrossrefPubMedGoogle Scholar
  • 6 Kasper W, Konstantinides S, Geibel A. , et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997; 30 (05) 1165-1171
    CrossrefPubMedGoogle Scholar
  • 7 Wood KE. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 2002; 121 (03) 877-905
    CrossrefPubMedGoogle Scholar
  • 8 Jaff MR, McMurtry MS, Archer SL. , et al; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011; 123 (16) 1788-1830
    CrossrefPubMedGoogle Scholar
  • 9 Konstantinides SV, Torbicki A, Agnelli G. , et al; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35 (43) 3033-3069 , 3069a–3069k
    CrossrefPubMedGoogle Scholar
  • 10 Kearon C, Akl EA, Ornelas J. , et al. Antithrombotic therapy for VTE disease: CHEST guideline. Chest 2016; 149 (02) 315-352
    CrossrefPubMedGoogle Scholar
  • 11 Jiménez D, Aujesky D, Yusen RD. Risk stratification of normotensive patients with acute symptomatic pulmonary embolism. Br J Haematol 2010; 151 (05) 415-424
    CrossrefPubMedGoogle Scholar
  • 12 Moons KG, Royston P, Vergouwe Y, Grobbee DE, Altman DG. Prognosis and prognostic research: what, why, and how?. BMJ 2009; 338: b375
    CrossrefPubMedGoogle Scholar
  • 13 Royston P, Moons KG, Altman DG, Vergouwe Y. Prognosis and prognostic research: developing a prognostic model. BMJ 2009; 338: b604
    CrossrefPubMedGoogle Scholar
  • 14 Altman DG, Vergouwe Y, Royston P, Moons KG. Prognosis and prognostic research: validating a prognostic model. BMJ 2009; 338: b605
    CrossrefPubMedGoogle Scholar
  • 15 Moons KG, Altman DG, Vergouwe Y, Royston P. Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ 2009; 338: b606
    CrossrefPubMedGoogle Scholar
  • 16 McGinn TG, Guyatt GH, Wyer PC, Naylor CD, Stiell IG, Richardson WS. ; Evidence-Based Medicine Working Group. Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. JAMA 2000; 284 (01) 79-84
    CrossrefPubMedGoogle Scholar
  • 17 Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353 (9162): 1386-1389
    CrossrefPubMedGoogle Scholar
  • 18 Barrios D, Yusen RD, Jiménez D. Risk stratification for proven acute pulmonary embolism: what information is needed? Semin Respir Crit Care Med. DOI: doi.org/10.1093/eurheartj/ehn310.
    PubMedGoogle Scholar
  • 19 Wicki J, Perrier A, Perneger TV, Bounameaux H, Junod AF. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost 2000; 84 (04) 548-552
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 20 Jiménez D, Yusen RD, Otero R. , et al. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Chest 2007; 132 (01) 24-30
    CrossrefPubMedGoogle Scholar
  • 21 Aujesky D, Obrosky DS, Stone RA. , et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005; 172 (08) 1041-1046
    CrossrefPubMedGoogle Scholar
  • 22 Aujesky D, Roy PM, Le Manach CP. , et al. Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J 2006; 27 (04) 476-481
    CrossrefPubMedGoogle Scholar
  • 23 Chan CM, Woods C, Shorr AF. The validation and reproducibility of the pulmonary embolism severity index. J Thromb Haemost 2010; 8 (07) 1509-1514
    CrossrefPubMedGoogle Scholar
  • 24 Aujesky D, Perrier A, Roy PM. , et al. Validation of a clinical prognostic model to identify low-risk patients with pulmonary embolism. J Intern Med 2007; 261 (06) 597-604
    CrossrefPubMedGoogle Scholar
  • 25 Erkens PM, Gandara E, Wells PS. , et al. Does the Pulmonary Embolism Severity Index accurately identify low risk patients eligible for outpatient treatment?. Thromb Res 2012; 129 (06) 710-714
    CrossrefPubMedGoogle Scholar
  • 26 Jiménez D, Aujesky D, Moores L. , et al; RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010; 170 (15) 1383-1389
    CrossrefPubMedGoogle Scholar
  • 27 Lankeit M, Gómez V, Wagner C. , et al; Instituto Ramón y Cajal de Investigación Sanitaria Pulmonary Embolism Study Group. A strategy combining imaging and laboratory biomarkers in comparison with a simplified clinical score for risk stratification of patients with acute pulmonary embolism. Chest 2012; 141 (04) 916-922
    CrossrefPubMedGoogle Scholar
  • 28 Righini M, Roy PM, Meyer G, Verschuren F, Aujesky D, Le Gal G. The Simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism. J Thromb Haemost 2011; 9 (10) 2115-2117
    CrossrefPubMedGoogle Scholar
  • 29 Spirk D, Aujesky D, Husmann M. , et al. Cardiac troponin testing and the simplified Pulmonary Embolism Severity Index. The SWIss Venous ThromboEmbolism Registry (SWIVTER). Thromb Haemost 2011; 106 (05) 978-984
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 30 Aujesky D, Roy PM, Verschuren F. , et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 2011; 378 (9785): 41-48
    CrossrefPubMedGoogle Scholar
  • 31 Zondag W, Mos IC, Creemers-Schild D. , et al; Hestia Study Investigators. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J Thromb Haemost 2011; 9 (08) 1500-1507
    CrossrefPubMedGoogle Scholar
  • 32 den Exter PL, Zondag W, Klok FA. , et al. Efficacy and safety of outpatient treatment based on the Hestia clinical decision rule with or without NT-proBNP testing in patients with acute pulmonary embolism: a randomized clinical trial. Am J Respir Crit Care Med 2016; 194: 998-1006
    CrossrefPubMedGoogle Scholar
  • 33 Zondag W, den Exter PL, Crobach MJ. , et al; Hestia Study Investigators. Comparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolism. Thromb Haemost 2013; 109 (01) 47-52
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 34 Kohn CG, Mearns ES, Parker MW, Hernandez AV, Coleman CI. Prognostic accuracy of clinical prediction rules for early post-pulmonary embolism all-cause mortality: a bivariate meta-analysis. Chest 2015; 147 (04) 1043-1062
    CrossrefPubMedGoogle Scholar
  • 35 Marshall PS, Tapson V, Jiménez D. Controversies in the management of life-threatening pulmonary embolism. Semin Respir Crit Care Med 2015; 36 (06) 835-841
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 36 Binder L, Pieske B, Olschewski M. , et al. N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 2005; 112 (11) 1573-1579
    CrossrefPubMedGoogle Scholar
  • 37 Scridon T, Scridon C, Skali H, Alvarez A, Goldhaber SZ, Solomon SD. Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolism. Am J Cardiol 2005; 96 (02) 303-305
    CrossrefPubMedGoogle Scholar
  • 38 Jiménez D, Aujesky D, Moores L. , et al. Combinations of prognostic tools for identification of high-risk normotensive patients with acute symptomatic pulmonary embolism. Thorax 2011; 66 (01) 75-81
    CrossrefPubMedGoogle Scholar
  • 39 Sanchez O, Trinquart L, Caille V. , et al. Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study. Am J Respir Crit Care Med 2010; 181 (02) 168-173
    CrossrefPubMedGoogle Scholar
  • 40 Jiménez D, Kopecna D, Tapson V. , et al; On Behalf Of The Protect Investigators. Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolism. Am J Respir Crit Care Med 2014; 189 (06) 718-726
    CrossrefPubMedGoogle Scholar
  • 41 Dellas C, Tschepe M, Seeber V. , et al. A novel H-FABP assay and a fast prognostic score for risk assessment of normotensive pulmonary embolism. Thromb Haemost 2014; 111 (05) 996-1003
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 42 Bova C, Sanchez O, Prandoni P. , et al. Identification of intermediate-risk patients with acute symptomatic pulmonary embolism. Eur Respir J 2014; 44 (03) 694-703
    CrossrefPubMedGoogle Scholar
  • 43 Fernández C, Bova C, Sanchez O. , et al. Validation of a model for identification of patients at intermediate to high risk for complications associated with acute symptomatic pulmonary embolism. Chest 2015; 148 (01) 211-218
    CrossrefPubMedGoogle Scholar
  • 44 Hobohm L, Hellenkamp K, Hasenfuß G, Münzel T, Konstantinides S, Lankeit M. Comparison of risk assessment strategies for not-high-risk pulmonary embolism. Eur Respir J 2016; 47 (04) 1170-1178
    CrossrefPubMedGoogle Scholar